Correlation Between Equillium and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Equillium and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Cocrystal Pharma, you can compare the effects of market volatilities on Equillium and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Cocrystal Pharma.

Diversification Opportunities for Equillium and Cocrystal Pharma

-0.29

Correlation Coefficient

Equillium  Cocrystal Pharma

Very good diversification

The 3 months correlation between Equillium and Cocrystal is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Equillium i.e., Equillium and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Equillium and Cocrystal Pharma

Allowing for the 90-day total investment horizon Equillium is expected to generate 2.43 times less return on investment than Cocrystal Pharma. But when comparing it to its historical volatility, Equillium is 2.58 times less risky than Cocrystal Pharma. It trades about 0.17 of its potential returns per unit of risk. Cocrystal Pharma is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  188.00  in Cocrystal Pharma on October 6, 2024 and sell it today you would earn a total of  47.00  from holding Cocrystal Pharma or generate 25.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Cocrystal Pharma

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Cocrystal Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Equillium and Cocrystal Pharma

The main advantage of trading using opposite Equillium and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Equillium and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.